6/18
10:43 am
crsp
Global Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, ZFN), Delivery Method (Ex-vivo, In-vivo) 2024-2030 [Yahoo! Finance]
Low
Report
Global Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, ZFN), Delivery Method (Ex-vivo, In-vivo) 2024-2030 [Yahoo! Finance]
6/17
02:05 pm
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $105.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $105.00 price target on the stock.
6/17
08:06 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $88.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $88.00 price target on the stock.
6/14
06:32 am
crsp
CRISPR Therapies Market Research 2024: Pipeline Analysis, Therapeutic Assessment, Unmet Needs, Impact of Drugs [Yahoo! Finance]
Low
Report
CRISPR Therapies Market Research 2024: Pipeline Analysis, Therapeutic Assessment, Unmet Needs, Impact of Drugs [Yahoo! Finance]
6/13
08:06 pm
crsp
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know [Yahoo! Finance]
6/10
10:45 am
crsp
Crispr Therapeutics, Futurism-Turning-Commercial, Defies 'Valuation' (Technical Analysis) [Seeking Alpha]
Low
Report
Crispr Therapeutics, Futurism-Turning-Commercial, Defies 'Valuation' (Technical Analysis) [Seeking Alpha]
6/9
06:25 am
crsp
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought [Yahoo! Finance]
Medium
Report
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought [Yahoo! Finance]
6/7
11:57 pm
crsp
Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report? [Yahoo! Finance Canada]
Medium
Report
Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report? [Yahoo! Finance Canada]
6/7
06:34 pm
crsp
The 'Undercovered' Dozen From June 1-6 [Seeking Alpha]
Medium
Report
The 'Undercovered' Dozen From June 1-6 [Seeking Alpha]
6/7
01:21 pm
crsp
Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report? [Yahoo! Finance]
6/7
12:25 pm
crsp
Cathie Wood Invests In 2 Biotechnology Stocks – Are They Worth Buying? [Yahoo! Finance]
Low
Report
Cathie Wood Invests In 2 Biotechnology Stocks – Are They Worth Buying? [Yahoo! Finance]
6/4
06:52 am
crsp
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? [Yahoo! Finance]
Low
Report
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? [Yahoo! Finance]
5/31
10:48 am
crsp
Swiss biotech ecosystem recuperates from global financial instability [Yahoo! Finance]
Low
Report
Swiss biotech ecosystem recuperates from global financial instability [Yahoo! Finance]
5/31
05:47 am
crsp
Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You? [Yahoo! Finance]
Low
Report
Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You? [Yahoo! Finance]
5/31
04:24 am
crsp
Genome Editing Technologies market is projected to grow at a CAGR of 17.6% by 2034: Visiongain [Yahoo! Finance]
Low
Report
Genome Editing Technologies market is projected to grow at a CAGR of 17.6% by 2034: Visiongain [Yahoo! Finance]
5/29
08:12 am
crsp
CRISPR Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
CRISPR Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
5/29
08:00 am
crsp
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
5/23
01:42 pm
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target lowered by analysts at Citigroup Inc. from $89.00 to $84.00. They now have a "buy" rating on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target lowered by analysts at Citigroup Inc. from $89.00 to $84.00. They now have a "buy" rating on the stock.
5/23
08:15 am
crsp
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments Thu, May 23, 2024, 2:00 PM GMT+2 5 min read 0 In this article: Advertisement Up next Should You Buy QuantumScape Stock While It's Below $10? Thu, May 23, 2024, 10:50 AM GMT+2
Medium
Report
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments Thu, May 23, 2024, 2:00 PM GMT+2 5 min read 0 In this article: Advertisement Up next Should You Buy QuantumScape Stock While It's Below $10? Thu, May 23, 2024, 10:50 AM GMT+2
5/23
08:00 am
crsp
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
Low
Report
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
5/22
09:37 am
crsp
Is CRISPR Therapeutics a Millionaire Maker? [Yahoo! Finance]
Medium
Report
Is CRISPR Therapeutics a Millionaire Maker? [Yahoo! Finance]
5/22
06:47 am
crsp
Bull Market Buys: 2 Growth Stocks to Own for the Long Run [Yahoo! Finance]
Medium
Report
Bull Market Buys: 2 Growth Stocks to Own for the Long Run [Yahoo! Finance]
5/21
01:15 pm
crsp
Vertex (VRTX) Outperforms Industry on Rapid Pipeline Progress [Yahoo! Finance]
Low
Report
Vertex (VRTX) Outperforms Industry on Rapid Pipeline Progress [Yahoo! Finance]
5/17
09:35 am
crsp
Is CRISPR Therapeutics Stock a Buy? [Yahoo! Finance]
Low
Report
Is CRISPR Therapeutics Stock a Buy? [Yahoo! Finance]
5/16
09:03 am
crsp
How Gene Editing Therapies Could Go Beyond Rare Diseases [Forbes]
Low
Report
How Gene Editing Therapies Could Go Beyond Rare Diseases [Forbes]